Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days.
Waddell
J A
JA
Department of Pharmacy, Brooke Army Medical Center, Fort Sam Houston, TX 78234, USA. aubrey.waddell@cen.amedd.army.mil
Coleman
T A
TA
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D004868:Equipment Failure; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D007262:Infusions, Intravenous; D008508:Medication Errors / Q000009:adverse effects*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine; D004317:Doxorubicin